Geode Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13M Buy
1,596,329
+207,097
+15% +$1.69M ﹤0.01% 2181
2025
Q1
$10.9M Buy
1,389,232
+179,619
+15% +$1.41M ﹤0.01% 2236
2024
Q4
$18M Sell
1,209,613
-12,593
-1% -$188K ﹤0.01% 2021
2024
Q3
$18.7M Sell
1,222,206
-10,869
-0.9% -$166K ﹤0.01% 2013
2024
Q2
$18.8M Buy
1,233,075
+61,107
+5% +$931K ﹤0.01% 1961
2024
Q1
$22.1M Buy
1,171,968
+29,799
+3% +$563K ﹤0.01% 1871
2023
Q4
$21.8M Buy
1,142,169
+64,576
+6% +$1.23M ﹤0.01% 1854
2023
Q3
$19.3M Buy
1,077,593
+48,671
+5% +$874K ﹤0.01% 1846
2023
Q2
$20.9M Buy
1,028,922
+50,755
+5% +$1.03M ﹤0.01% 1826
2023
Q1
$17.8M Buy
978,167
+31,694
+3% +$578K ﹤0.01% 1880
2022
Q4
$19.6M Buy
946,473
+35,115
+4% +$726K ﹤0.01% 1788
2022
Q3
$23.8M Buy
911,358
+65,963
+8% +$1.73M ﹤0.01% 1604
2022
Q2
$21.4M Buy
845,395
+47,853
+6% +$1.21M ﹤0.01% 1723
2022
Q1
$25.2M Buy
797,542
+28,030
+4% +$885K ﹤0.01% 1730
2021
Q4
$31.1M Sell
769,512
-13,664
-2% -$553K ﹤0.01% 1667
2021
Q3
$27.3M Buy
783,176
+11,622
+2% +$405K ﹤0.01% 1742
2021
Q2
$21.2M Buy
771,554
+60,032
+8% +$1.65M ﹤0.01% 1922
2021
Q1
$20M Buy
711,522
+65,431
+10% +$1.84M ﹤0.01% 1882
2020
Q4
$16.8M Buy
646,091
+30,237
+5% +$785K ﹤0.01% 1833
2020
Q3
$10.6M Buy
615,854
+63,165
+11% +$1.08M ﹤0.01% 1909
2020
Q2
$13.7M Buy
552,689
+112,048
+25% +$2.77M ﹤0.01% 1747
2020
Q1
$6.12M Buy
440,641
+45,647
+12% +$634K ﹤0.01% 2022
2019
Q4
$3.99M Buy
394,994
+9,907
+3% +$100K ﹤0.01% 2594
2019
Q3
$3.5M Buy
385,087
+154,732
+67% +$1.41M ﹤0.01% 2599
2019
Q2
$1.83M Buy
230,355
+27,360
+13% +$217K ﹤0.01% 3006
2019
Q1
$2.54M Buy
202,995
+21,823
+12% +$273K ﹤0.01% 2707
2018
Q4
$1.95M Buy
181,172
+83,193
+85% +$896K ﹤0.01% 2788
2018
Q3
$1.37M Buy
97,979
+18,748
+24% +$261K ﹤0.01% 3087
2018
Q2
$969K Buy
+79,231
New +$969K ﹤0.01% 3201